Earnings Call Insights: PubMatic (PUBM) Q1 2026 Management view "We delivered an exceptional first quarter with revenue and adjusted EBITDA ahead of guidance," said (Co-Founder, CEO & Director Rajeev Goel), adding that "emerging revenues grew over 80% year-over-year and climbed to 14% of total revenues, aided by AgenticOS." Goel tied the company’s strategy to a shift toward "AI-driven agentic adve...
Earnings Call Insights: PubMatic (PUBM) Q1 2026 Management view "We delivered an exceptional first quarter with revenue and adjusted EBITDA ahead of guidance," said (Co-Founder, CEO & Director Rajeev Goel), adding that "emerging revenues grew over 80% year-over-year and climbed to 14% of total revenues, aided by AgenticOS." Goel tied the company’s strategy to a shift toward "AI-driven agentic advertising" and said the summer 2025 strategy is "diversifying our DSP mix, growing in high consumer engagement channels such as CTV and mobile app and creating more value for key stakeholders." He also highlighted partnerships and integrations, including Amazon’s Dynamic Traffic Engine "now launched globally" and said early results showed "up to a 10% increase in CPM since its launch." "We delivered a strong quarter with Q1 revenue of $62.6 million and adjusted EBITDA of $2.6 million," said (Chief Financial Officer Steven Pantelick). "We also generated $10.7 million of free cash flow, a 17% free cash flow margin and returned value to shareholders through the repurchase of 1 million Class A common shares." Pantelick emphasized infrastructure and efficiency, stating the platform "efficiently process[es] over 1 trillion impressions per day," and said the company will "continue shifting our investment away from predominant capacity expansion towards targeted GPU-centric infrastructure" supporting CTV, mobile app, live sports and AgenticOS. Outlook Pantelick said PubMatic "expect[s] Q2 revenue to be in the range of $68 million to $70 million" and "Q2 adjusted EBITDA is expected to be in the range of $8 million to $10 million" while assuming "a similar FX headwind as Q1." On the legacy DSP headwind, Pantelick reiterated that Q2 "includes the impact from the legacy DSP" and that "Beginning in Q3, we expect to return to revenue growth and accelerate through the second half," with "margin expansion supported by targeted investments in sales and AI products, expense discipline and cont...
Reform makes gains in Labour’s working-class heartlands while Greens chip away at party’s progressive base Keir Starmer hates to lose. Unsurprisingly, he refused to walk away and end his premiership as Labour’s local election losses began to trickle in on Friday morning. Upon entering Downing Street in July 2024 after leading Labour to a historic general election victory, Starmer promised the publ...
Reform makes gains in Labour’s working-class heartlands while Greens chip away at party’s progressive base Keir Starmer hates to lose. Unsurprisingly, he refused to walk away and end his premiership as Labour’s local election losses began to trickle in on Friday morning. Upon entering Downing Street in July 2024 after leading Labour to a historic general election victory, Starmer promised the public that his government would “fight every day until you believe again”. Now, Starmer is faced with the uncomfortable truth that the frustrated yet united coalition that brought him into No 10 hoping for change is completely fractured and its discontent cannot be dismissed as early midterm blues. Continue reading...
Taiwan Semiconductor April Sales Grow At Slowest Pace In 6 Months Taiwan Semiconductor, world's largest dedicated independent semiconductor foundry, posted its slowest pace of monthly revenue expansion since October, highlighting the challenges of sustaining torrid AI-fueled pace of growth. Sales in April rose 17.5% to NT$410.7 billion ($13.1 billion), their smallest rise in about six months. Whil...
Taiwan Semiconductor April Sales Grow At Slowest Pace In 6 Months Taiwan Semiconductor, world's largest dedicated independent semiconductor foundry, posted its slowest pace of monthly revenue expansion since October, highlighting the challenges of sustaining torrid AI-fueled pace of growth. Sales in April rose 17.5% to NT$410.7 billion ($13.1 billion), their smallest rise in about six months. While the rise reflects just 30 days of business and its revenue can fluctuate month-to-month, the drop was notable; analysts expect the company’s June-quarter revenue to grow almost twice as fast, or at about 35% which means that May and June sales will have to be gangbusters to compensate for April's slowness. Taiwan’s largest company has become an essential player in the global AI industry by making cutting-edge semiconductors for the likes of Nvidia and AMD. That’s as Alphabet, Amazon.com, Meta and Microsoft said they are setting aside $725 billion for AI this year, significantly more than previously anticipated. The question of where all this money will come from will be the next big hurdle for the market (we discussed it here "" Banks Are Choking": The AI Debt Bubble Has Started To Burst ".) Offsetting the huge AI orderbook are plateauing smartphone and consumer electronics sales, where soaring memory chip costs are forcing brands to hike prices leading to a big drop in demand. Economic uncertainty is also dampening consumer demand in many parts of the world. For its part, TSMC has remained bullish on global AI chip demand. In April, the company raised its full-year sales guidance and said its own capital spending should trend toward the upper end of an existing forecast range of as much as $56 billion, conveying confidence in the year’s economic outlook. Tyler Durden Fri, 05/08/2026 - 14:40
Isomorphic Labs , an AI-powered drug discovery company spun out of Alphabet Inc. ’s Google DeepMind, is in advanced discussions to raise more than $2 billion in a new round of funding, according to people familiar with the plan. Thrive Capital , the venture firm that led Isomorphic Labs’ first funding round last year, is set to lead the new financing, said the people, who spoke on condition of ano...
Isomorphic Labs , an AI-powered drug discovery company spun out of Alphabet Inc. ’s Google DeepMind, is in advanced discussions to raise more than $2 billion in a new round of funding, according to people familiar with the plan. Thrive Capital , the venture firm that led Isomorphic Labs’ first funding round last year, is set to lead the new financing, said the people, who spoke on condition of anonymity as the information is not public. Alphabet is also participating, one person said, though the round is not yet closed. Isomorphic Labs is one of a growing number of businesses attempting to apply advances in AI to speed up drug discoveries and cut the costs of such work, despite many failures from Silicon Valley to expand into health and life sciences. Google rival OpenAI, also backed by Thrive, recently introduced a new AI model meant to help accelerate drug discovery. Thrive and Isomorphic Labs declined to comment. Google did not immediately respond to a request for comment. The additional funding would mark another step in Alphabet’s longtime plan to turn its futuristic bets into standalone businesses. Waymo, Alphabet’s autonomous driving unit, raised $16 billion at a $126 billion valuation earlier this year. Isomorphic Labs plans to use the new capital for its drug design engine, as well as to expand the business globally, one of the people said. The London-based company, formed in 2021, spun out of DeepMind to explore commercial potential for AlphaFold, an AI program for predicting protein structures. DeepMind Chief Executive Officer Demis Hassabis also runs Isomorphic Labs, which has recruited heavily from its sister company. The drug discovery unit forged partnerships with pharmaceutical firms Johnson & Johnson and Eli Lilly & Co in 2024. The next year, it announced an agreement to expand its work with Novartis.
In this article RKLB Follow your favorite stocks CREATE FREE ACCOUNT Cheng Xin | Getty Images Rocket Lab 's stock blasted 30% to a record high after the space company topped first-quarter revenue estimates and announced its largest launch deal on record. The Long Beach, California-based company reported $136.7 million in revenue for its space systems business and $63.7 million for its launch segme...
In this article RKLB Follow your favorite stocks CREATE FREE ACCOUNT Cheng Xin | Getty Images Rocket Lab 's stock blasted 30% to a record high after the space company topped first-quarter revenue estimates and announced its largest launch deal on record. The Long Beach, California-based company reported $136.7 million in revenue for its space systems business and $63.7 million for its launch segment. That topped FactSet estimates of $132.1 million and $59 million, respectively. Rocket Lab's backlog more than doubled from a year ago to $2.2 billion. Guidance also surpassed Wall Street's estimates. The company anticipates revenue between $225 million and $240 million during the second quarter, compared to a $207.5 million from LSEG. Rocket Lab's stock has more than quadrupled over the last year, benefiting from skyrocketing demand for businesses tied to the space economy ahead of SpaceX 's hotly anticipated IPO later this year. Demand for space systems and satellites is also escalating as President Donald Trump pursues his ambitious Golden Dome project and NASA's crewed Artemis missions rev up. Read more CNBC tech news OpenAI trial: Mother of Musk's children says he offered Altman a Tesla board seat Paul Tudor Jones says U.S. is late to regulating AI: 'We should have already done it' CoreWeave revenue more than doubles in first quarter, topping estimates Datadog stock soars 31% on blockbuster earnings as AI winners emerge in software Rocket Lab said Thursday that it signed its largest contract ever with a confidential customer for its Neutron and Electron rockets through 2029, weeks after landing a $190 million deal for 20 hypersonic test flights. The company is also buying space robotics maker Motiv Space Systems . "The demand signal is clear," CEO Peter Beck said on an earnings call with analysts, calling the pace of new product releases from the company this year "relentless." The company is gearing up for the first launch of its Neutron rocket after a qualificatio...
Shares of Teladoc Health ( TDOC ) rose more than 4% Friday, extending their winning streak to seven consecutive sessions. The stock has climbed roughly 22% since April 30, rising from a closing price of $5.95 to around ~$7.30 on Friday. Over the past month, shares have gained 38%, though the stock remains up just 2.7% year-to-date, trailing the broader S&P 500 ( SPX ), which has gains of about 7%....
Shares of Teladoc Health ( TDOC ) rose more than 4% Friday, extending their winning streak to seven consecutive sessions. The stock has climbed roughly 22% since April 30, rising from a closing price of $5.95 to around ~$7.30 on Friday. Over the past month, shares have gained 38%, though the stock remains up just 2.7% year-to-date, trailing the broader S&P 500 ( SPX ), which has gains of about 7%. Teladoc last closed in negative territory on April 29, when shares slipped 0.83% after the company reported a first-quarter earnings miss, snapping a three-day winning streak. Recent bullish sentiment has been around Teladoc’s transition from a cyclical direct-to-consumer telehealth model toward a higher-margin, data-driven business-to-business healthcare platform. Seeking Alpha analyst said the company was positioned as a “next-gen healthcare platform,” given its insurance-based revenue model, expanding integrated-care offerings, and its PulseAI platform, which uses patient data to proactively identify and manage high-risk patients. Analyst also pointed to improving EBITDA margins, positive free cash flow, and a stronger balance sheet as signs the company is entering a more scalable profitability phase that could support a future valuation re-rating. Among 26 Wall Street analysts covering the stock, six rate it “strong buy,” one has a "buy" rating, and the remaining 19 maintain "hold" ratings. More on Teladoc Health Teladoc Health, Inc. 2026 Q1 - Results - Earnings Call Presentation Teladoc Health, Inc. (TDOC) Q1 2026 Earnings Call Transcript Teladoc Health: Improving Fundamentals Support A Turnaround Story Teladoc outlines BetterHelp insurance exit run rate of $125M+ in 2026 as Integrated Care mix shift nears 70% visit-based Teladoc falls following Q1 EPS miss; 2026 guidance ranges include consensus
PM Images/DigitalVision via Getty Images The so-called “neoclouds” (specialized providers of AI-related data center compute) have been a favorite play for investors looking to take advantage of the AI trade. One of the favorites—CoreWeave, Inc. ( CRWV )—just reported Q1 2026 earnings. In this article, we will review the highlights of that earnings report and discuss how the latest numbers fit into...
PM Images/DigitalVision via Getty Images The so-called “neoclouds” (specialized providers of AI-related data center compute) have been a favorite play for investors looking to take advantage of the AI trade. One of the favorites—CoreWeave, Inc. ( CRWV )—just reported Q1 2026 earnings. In this article, we will review the highlights of that earnings report and discuss how the latest numbers fit into a longer-term thesis on the company. It will be my contention that the latest figures offer no reason for a materially different view of the company based on fundamentals, a company whose stock continues to present significant downside risk for investors at current prices. Comments On Commonly Referenced Metrics Before diving into the latest quarterly numbers, I think a bit of commentary on what metrics to look at and what metrics to disregard is in order. Of course, managements are always going to want to spin things to try to leave investors with a certain impression. I think one needs to be especially wary of these sorts of issues, though, when reviewing CoreWeave’s earnings. The most insidious examples of what I’m talking about here are some of the non-GAAP metrics that management uses, presumably to try to create the impression that things are far rosier than the picture painted by the GAAP figures would suggest. Here are a few examples. Adjusted EBITDA: Source: Earnings Release, with highlights by author My translation: “As long as you don’t count some of the most important costs that are intrinsic to our business—especially depreciation and amortization, as well as interest expense—we're very profitable!” Adjusted Operating Income: Source: Earnings Release, with highlights by author My translation: “As long as you act like stock-based compensation is not really an expense, we actually have an operating profit!” No, I think investors need to stick very close to the GAAP figures here while using a very skeptical lens when evaluating any non-GAAP metrics. Reviewing The...
Femen and Pussy Riot protest in Venice, Israeli strikes in Gaza, the hantavirus outbreak and Emma Chamberlain at the Met Gala – the past seven days as captured by the world’s leading photojournalists Continue reading...
Femen and Pussy Riot protest in Venice, Israeli strikes in Gaza, the hantavirus outbreak and Emma Chamberlain at the Met Gala – the past seven days as captured by the world’s leading photojournalists Continue reading...
Google has reached a settlement with Black employees who alleged systemic racial disparities in hiring, pay, and advancement in a lawsuit filed in 2022. April Curley, a former Google employee, had sued the tech giant for racial discrimination, saying it engages in a “pattern and practice” of unfair treatment for its Black workers. Other former Google workers also joined the suit, which later recei...
Google has reached a settlement with Black employees who alleged systemic racial disparities in hiring, pay, and advancement in a lawsuit filed in 2022. April Curley, a former Google employee, had sued the tech giant for racial discrimination, saying it engages in a “pattern and practice” of unfair treatment for its Black workers. Other former Google workers also joined the suit, which later received class action status.